Stealth nanocarriers based sterosomes using PEG post-insertion process.

Area of Science:

• Nanotechnology
• Materials Science
• Biomedical Engineering

Background:

• Sterosomes (STEs) are a promising non-phospholipidic liposome platform utilizing palmitic acid (PA) and cholesterol (Chol).
• Achieving long circulation times for nanocarriers requires surface modification, typically with polyethylene glycol (PEG) chains.

Purpose of the Study:

• To investigate the post-insertion of PEG-modified distearoylphosphoethanolamine (DSPE-PEG) onto STEs.
• To evaluate the impact of PEGylation on STE properties, including circulation time, immune response, and stability.

Main Methods:

• A post-insertion method was employed to graft DSPE-PEG chains onto the surface of STEs.
• Zeta potential measurements were used to monitor the PEGylation process.
• In vitro assays assessed complement activation and macrophage uptake.
• In vivo studies in mice evaluated blood circulation times.

Main Results:

• Zeta potential shifted from approximately -40mV (non-modified STEs) to near 0mV (PEG-modified STEs).
• PEGylation did not significantly affect STE stability or DSPE-PEG insertion kinetics across tested conditions.
• Post-insertion of PEG chains reduced in vitro complement activation and macrophage uptake.
• PEG-modified STEs exhibited significantly longer blood circulation times in mice compared to non-modified STEs.

Conclusions:

• Post-insertion of PEG chains onto STEs is an effective strategy for creating long-circulating nanocarriers.
• This PEGylation approach enhances stealth properties, reducing immune clearance.
• PEG-modified STEs represent a promising platform for advanced drug delivery systems.